In Practise Logo
In Practise Logo - Blue
In Practise Logo
Partner Interview
Published March 20, 2023

Atlassian: Confluence Strategy & Competition

Executive Bio

Former Program Management executive at Atlassian

Interview Transcript

Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.

This is a snippet of the transcript.to get full access.

What were the major levers you pulled to drive that?

Part of it was launching premium with key features standalone customers wanted. Marketing positioning is probably the biggest opportunity for Confluence to figure out in order for them to distinguish themselves from Asana and Notion.

This is a snippet of the transcript.to get full access.

Atlassian's messaging is around flexibility but Microsoft has a similar product positioning and deep entrenchment in enterprise with a price advantage in some cases?

They do not have a price advantage today but I have heard rumors they are undercutting people simply to land in enterprise. Once you are in enterprise, things get sticky because it's too hard to switch and the cost of switching is way too high.

This is a snippet of the transcript.to get full access.

Could you give some examples of what Confluence still needs to build?

The Fluid Framework is the best way to describe what they need to build. It's a notion that there is no defined way of how people work, so we cannot enforce it. People will gravitate to the product they want for work, and we need to adapt to it. Microsoft's Fluid Framework is where the industry is going, Monday is also doing that. You can bring blocks from every product into ours and make it work seamlessly.

This is a snippet of the transcript.to get full access.

Free Sample of 50+ Interviews

Sign up to test our content quality with a free sample of 50+ interviews.

Or contact sales for full access

© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.